Company Directory / Pharmaceuticals
Public · NASDAQ:GWPHFor profitPharmaceuticalsCambridge, United Kingdom
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
- Founded
- 1998 28 years ago
- Staff
- 51-100 231 on LinkedIn
- Followers
- 27k on LinkedIn
- Funding
- $1.2B as listed, USD
GW Pharmaceuticals is now part of Jazz Pharmaceuticals. Follow us at https://www.linkedin.com/company/jazz-pharmaceuticals
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 231 people list it on LinkedIn.
Age
28 years old.
Reach
No web traffic ranking listed. 26,911 followers on LinkedIn.
What it does
BiotechnologyCannabisHealth CarePharmaceuticalTherapeutics
Funding, as listed
$1.2B raised in total
- Rounds6
- LatestPost ipo equity, Oct 2018
- Latest amountUSD 345,230,000
- Investors1
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Funding filed with regulators
GW Pharmaceuticals filed one raise. Filings say how much was sold and to how many investors; they never name the investors.
- May 2021Amount not statedUK share allotment
Every detail we hold
Everything the source datasets list about GW Pharmaceuticals, field by field. Contact details are held but never shown.
The company
- Name
- GW Pharmaceuticals
- Type
- For profit
- Status
- Public · NASDAQ:GWPH
- Founded
- 1998
- Founders
- Brian Whittle, Geoffrey Guy
- Industry
- Pharmaceuticals
- Categories
- Biotechnology, Cannabis, Health Care, Pharmaceutical, Therapeutics
Where
- City
- Cambridge
- Country
- United Kingdom
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 231
- LinkedIn followers
- 26,911
Funding, as listed
- Total
- $1,220,530,000 USD
- Rounds
- 6
- Latest round
- Post ipo equity
- Latest round date
- Oct 2018
- Latest amount
- 345,230,000 USD
- Investors
- 1
- Stock listing
- NASDAQ:GWPH
- Listing status
- public
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
GW Pharmaceuticals may be growing as indicated by its inclusion in a global analysis report that forecasts the cannabis capsule market, in which GW Pharmaceuticals operates, to reach $79.2 billion by 2028. This suggests a positive outlook for the company within a growing industry. Additionally, the company is mentioned in the context of the European medical marijuana market, which is experiencing a notable compound annual growth rate of 19.0% through 2028, further implying a favorable environment for GW Pharmaceuticals' growth. The company's presence in these reports indicates its relevance in key markets that are expanding.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Pharmaceuticals in United Kingdom.
Ferring Controlled TherapeuticsEast Kilbride · 5001-10000 people · 1k followers
Oxford BioMedicaOxford · 501-1000 people · 47k followers
Redx PharmaAlderley Park · 51-100 people · 12k followers
Archimedes PharmaReading · 51-100 people · 4k followersCCellZome51-100 people · 2k followers
EUSA PharmaHemel Hempstead · 51-100 people · 14k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.